HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

Lifestyle risk factors in the progression of MS

389 Views 0 Replies

0 Members and 1 Guest are viewing this topic.

Lifestyle risk factors in the progression of MS
on:
#1
From the MS International Federation newsletter, March 15, 2017:

Quote
Lifestyle risk factors in the progression of multiple sclerosis

Low vitamin D levels and smoking consistently associated with MS progression


MS is the result of a complex, and yet unknown, interaction between the genes that we inherit and the environment in which we live. Any risk factors that can be avoided by simple modifications, such as those changes in a person’s lifestyle, are particularly important because they may require a lower cost than other risk factors.

In this study from Southern California, USA, researchers reviewed previously published articles on risk factors and exposures associated with MS progression and summarised their findings. Of the 59 studies meeting inclusion criteria, they found that many studies reported conflicting results or used different measures, making it difficult to draw any clear conclusions.

However, many of these studies agree that MS progression was consistently related to smoking and low levels of vitamin D were associated with higher EDSS scores. Smoking was also associated with a faster progression of disability in people with MS. The authors underlined the urgent need for more studies in different populations to further clarify MS risk factors in future.


The article concludes with a link to the PubMed abstract of the article entitled "A systematic review of modifiable risk factors in the progression of multiple sclerosis":

MS progression was consistently associated with low vitamin D levels, and smoking was associated with a more rapid decline in MS disability. Studies used a variety of methods, predictors, and outco...
PubMed · ncbi.nlm.nih.gov


MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.